KLK3 and posterior cortical atrophy: Current diagnostic approaches for PCa patients rely mainly on the measurement of prostate-specific antigen (PSA) levels; 0.5 ~ 2 ng/ml is the normal range, and above 4.0 ng/ml is the abnormal range [8,9].